In vivo behavior of monocytes in resting and inflammatory conditions

描述（由申请方提供）：保护受损或感染的组织涉及迁移性白细胞的协调递送。因此，目前的研究工作旨在确定控制这些细胞进出特定组织的机制。在这里，我们将研究单核细胞，因为这些细胞在组织炎症的协调和解决中起着核心作用，因此代表了治疗中有吸引力的靶点。被募集到组织中的单核细胞被认为仅来源于血液和骨髓。然而，最近的研究表明，脾脏含有真正的，未分化的单核细胞，数量超过其血液等价物。此外，脾单核细胞可以动员大量炎症部位后，适当的刺激。这些发现形成了我们假设的基础，即脾脏是储存和快速部署单核细胞的场所，并且脾脏单核细胞代表了身体用来控制炎症的重要资源。目前，有必要澄清脾脏相关的机制，控制单核细胞的稳态和功能。在第一个目标中，我们将测量定义静息脾中单核细胞生物学的参数（细胞更新，教育与维护，位置和组织以及体内行为）。这些研究对于揭示单核细胞行为的基本方面和脾作为单核细胞储存器官的作用是必要的。在第二个目标中，我们将定义用于动员脾单核细胞的机制。我们将研究AT-1受体-血管紧张素II（Ang II）信号转导，因为它是一个新发现的控制spM动员的途径。我们将定义spM对Ang II信号的反应，并研究是否可以通过调节Ang II信号来控制单核细胞的反应。我们的数据表明，抑制血管紧张素II信号取消部署的spM，从而抑制单核细胞反应在遥远的网站。因此，这些研究具有重要的治疗潜力。我们将使用实验室中可用的最先进的动物模型和读数;这些包括延时活体细胞成像以询问体内单核细胞的行为，以及对“最小接触”细胞进行分析以在不同组织中进行综合分析。在过去的三年里，我们已经开发和/或验证了这项技术，现在将应用它来回答与单核细胞相关的生物学问题。我们的实验将比较两个单核细胞亚群（Ly-6Chi和Ly-6Clo），因为它们似乎在免疫中发挥不同的作用，但它们的相对贡献需要澄清。体内成像将使用新产生的Cx 3cr 1gfp/+ Ccr 2 rfp/+小鼠，因为这些小鼠中的单核细胞亚群可以单独跟踪。该项目将与当地（MGH的Weissleder，Luster和Xavier; HMS的von Andrian）和外部（UCSF的Charo）免疫学，成像和系统生物学小组密切互动。

DESCRIPTION (provided by applicant): Protection of injured or infected tissue involves the coordinated delivery of migratory leukocytes. Thus, current research efforts aim to define the mechanisms that control the movement of these cells into and out of specific tissues. Here, we will study monocytes because these cells play a central role in the orchestration and resolution of tissue inflammation, and thus represent attractive targets in therapy. Monocytes recruited to tissue are thought to originate exclusively from blood and bone marrow. However, recent work indicates that the spleen contains bona fide, undifferentiated monocytes that outnumber their blood equivalents. Also, splenic monocytes can be mobilized massively to inflammatory sites upon appropriate stimulation. These findings form the basis of our hypothesis that the spleen is a site for storage and rapid deployment of monocytes, and that splenic monocytes represent a significant resource that the body exploits to control inflammation. At present, there is a need to clarify the spleen-associated mechanisms that control monocyte homeostasis and function. In a first aim, we will measure parameters that define the biology of monocytes in the resting spleen (cell turnover, education vs maintenance, location and organization, and in vivo behavior). These studies are necessary to uncover fundamental aspects of monocyte behavior and the role of the spleen as a monocyte storage organ. In a second aim, we will define mechanisms that are employed to mobilize splenic monocytes. We will study AT-1 receptor-Angiotensin II (Ang II) signaling because it is a newly identified pathway that controls mobilization of spM. We will define the spM response to Ang II signals, and study whether modulation of Ang II signaling can be used to control the monocyte response. Our data indicate that suppression of Ang II signaling abolishes the deployment of spM and consequently suppresses the monocyte response at distant sites. Thus, these studies have important therapeutic potential. We will use state-of-the-art animal models and readouts that are available in the laboratory; these include time-lapse intravital cellular imaging to interrogate the behavior of monocytes in vivo, and profiling of 'minimally- touched' cells for comprehensive analysis in distinct tissues. We have developed and/or validated the technology over the past three years, and will now apply it to answer the biological questions relevant to monocytes. Our experiments will compare two monocyte subsets (Ly-6Chi and Ly-6Clo) because they appear to play different roles in immunity, yet their relative contributions need clarification. In vivo imaging will use newly- generated Cx3cr1gfp/+ Ccr2rfp/+ mice because monocyte subsets in these mice can be followed separately. The project will interact closely with local (Weissleder, Luster and Xavier at MGH; von Andrian at HMS) and outside (Charo at UCSF) immunology, imaging and systems biology groups.